news studionews studio

美国AI医疗临床对话纪录平台Abridge近日宣布,成功获得了由Lightspeed和Redpoint Ventures共同领投的1.5亿美元C轮融资。此轮融资吸引了包括Mass General Brigham AIDIF、Kaiser Permanente Ventures、Bessemer Venture Partners以及CVS Health Ventures在内的多家现有投资者参与。这一巨额投资使Abridge的估值攀升至8.5亿美元,彰显了市场对AI在医疗记录领域应用的强劲信心。

Abridge致力于利用人工智能技术,将医生与患者间的临床对话录音转化为精准的医疗记录,从而提高医疗效率和准确性。自成立以来,该公司已与超过10000名临床医生签订了使用其软件的合同,显示出其技术在医疗行业中的广泛接受度和实用性。

此次融资将为Abridge提供更强大的资金支持,以加速其AI技术的研发和创新,进一步优化医疗记录流程,同时可能推动其在全球范围内的业务拓展。随着医疗数据的数字化进程加速,Abridge的解决方案有望在改善医疗服务质量和患者体验方面发挥更大作用。

Abridge的首席执行官表示,这笔资金将用于提升平台的智能化水平,以更好地协助医生和医疗机构应对日益增长的医疗记录需求,同时保证数据的安全性和隐私保护。通过与众多医疗行业领先机构的合作,Abridge正逐步构建一个以AI驱动的、更加高效和人性化的医疗信息管理体系。

英语如下:

**News Title:** “Abridge Raises $150M in Series C Funding, AI-Powered Medical Records Platform Valued at $850M”

**Keywords:** Abridge, AI in healthcare, funding

**News Content:**

Title: Abridge Secures $150M in Series C Funding, AI-Driven Medical Records Platform Valuation Jumps to $850M

American AI-powered clinical conversation platform Abridge recently announced it has closed a $150 million Series C funding round led by Lightspeed and Redpoint Ventures. The round saw participation from existing investors, including Mass General Brigham AIDIF, Kaiser Permanente Ventures, Bessemer Venture Partners, and CVS Health Ventures. This significant investment has propelled Abridge’s valuation to $8.5 billion, underscoring strong market confidence in AI applications within medical records.

Abridge focuses on using artificial intelligence to transcribe audio recordings of doctor-patient clinical conversations into precise medical records, enhancing healthcare efficiency and accuracy. Since its inception, the company has inked contracts with over 10,000 clinicians, demonstrating broad acceptance and practicality of its technology within the healthcare sector.

The new funding will bolster Abridge’s financial position, enabling it to accelerate AI research and innovation, further refine medical documentation processes, and potentially fuel expansion globally. As the digitization of medical data accelerates, Abridge’s solutions are poised to play an increasingly significant role in improving healthcare quality and patient experience.

Abridge’s CEO stated that the funds will be used to enhance the platform’s intelligence, better supporting doctors and healthcare facilities in managing the growing demand for medical records while maintaining data security and privacy. Through collaborations with leading institutions in the healthcare industry, Abridge is incrementally building an AI-driven, more efficient, and patient-centric medical information management system.

【来源】https://www.forbes.com/sites/katiejennings/2024/02/23/abridge-raises-150-million-to-make-ai-medical-scribes-even-smarter/

Views: 1

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注